• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[白细胞介素-10在乳腺癌患者肿瘤组织中的表达的预后价值]

[Prognostic value of IL-10 expression in tumor tissues of breast cancer patients].

作者信息

Li Ying, Yu Haiming, Jiao Shunchang, Yang Junlan

机构信息

Department of Medical Oncology, PLA General Hospital, Beijing 100853, China.

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 May;30(5):517-20.

PMID:24796749
Abstract

OBJECTIVE

To evaluate the prognostic value of IL-10 expression in breast cancer patients and determine the correlation between IL-10 expression and clinicopathological features of breast cancer.

METHODS

Paraffin sections were retrospectively collected from 130 patients of stage I-III breast cancer who received surgery between January 2000 and December 2002 in the Chinese PLA General Hospital. The protein expression of IL-10 in the primary lesions was detected by immunohistochemistry to analyze the correlations of IL-10 expression with clinicopathological variables and prognosis.

RESULTS

IL-10 was found expressed in the cytoplasm of both tumor cells and stromal cells. Higher IL-10 expression in tumor cell cytoplasm was associated with lower T grade (P=0.012), higher SBR grade (P=0.004), positive ER (P=0.007), negative vascular invasion (P=0.034). The multivariant COX regression analysis showed that higher IL-10 expression in tumor cell cytoplasm was associated with better disease-free survival (HR=0.443, P=0.022) and that higher density of IL-10⁺; in stromal cell cytoplasm was associated with overall survival (HR=0.411, P=0.051).

CONCLUSION

IL-10 expression level in breast tumor cells and stromal cells can be used as a predictor of breast cancer prognosis. Low expression of IL-10 is associated with poor survival outcome.

摘要

目的

评估白细胞介素-10(IL-10)表达在乳腺癌患者中的预后价值,并确定IL-10表达与乳腺癌临床病理特征之间的相关性。

方法

回顾性收集2000年1月至2002年12月在中国人民解放军总医院接受手术的130例Ⅰ-Ⅲ期乳腺癌患者的石蜡切片。采用免疫组织化学法检测原发灶中IL-10的蛋白表达,分析IL-10表达与临床病理变量及预后的相关性。

结果

发现肿瘤细胞和基质细胞的细胞质中均有IL-10表达。肿瘤细胞细胞质中IL-10表达较高与较低的T分级(P=0.012)、较高的SBR分级(P=0.004)、雌激素受体阳性(P=0.007)、无血管侵犯(P=0.034)相关。多变量COX回归分析显示,肿瘤细胞细胞质中IL-10表达较高与无病生存期较好相关(HR=0.443,P=0.022),基质细胞细胞质中IL-10⁺密度较高与总生存期相关(HR=0.411,P=0.051)。

结论

乳腺肿瘤细胞和基质细胞中的IL-10表达水平可作为乳腺癌预后的预测指标。IL-10低表达与较差的生存结果相关。

相似文献

1
[Prognostic value of IL-10 expression in tumor tissues of breast cancer patients].[白细胞介素-10在乳腺癌患者肿瘤组织中的表达的预后价值]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 May;30(5):517-20.
2
Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer.MAC30 蛋白的表达与乳腺癌患者的生存和临床病理变量相关。
J Surg Oncol. 2013 Apr;107(5):456-62. doi: 10.1002/jso.23269. Epub 2012 Sep 20.
3
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.基质金属蛋白酶(MMP)-2和MMP-9在乳腺癌中的表达:特别提及激活蛋白-2、人表皮生长因子受体2(HER2)及预后
Clin Cancer Res. 2004 Nov 15;10(22):7621-8. doi: 10.1158/1078-0432.CCR-04-1061.
4
Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.基质细胞衍生因子-1 趋化因子在浸润性乳腺癌中的表达模式与雌激素受体状态和患者预后相关。
Breast Cancer Res Treat. 2010 Oct;123(3):733-45. doi: 10.1007/s10549-009-0672-y. Epub 2009 Dec 18.
5
Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer.在前列腺癌中,肿瘤和基质表达白细胞介素-1 和肿瘤坏死因子-α信号通路成分的临床意义。
Cytokine. 2013 Nov;64(2):555-63. doi: 10.1016/j.cyto.2013.09.003. Epub 2013 Sep 21.
6
Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.肝癌衍生生长因子(HDGF)定位对乳腺癌患者预后的价值。
Pathol Res Pract. 2012 Aug 15;208(8):437-43. doi: 10.1016/j.prp.2012.03.004. Epub 2012 Jun 8.
7
[Clinical characteristics and prognosis of breast cancer patients with vascular invasion].[伴有血管侵犯的乳腺癌患者的临床特征及预后]
Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):137-40.
8
Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.在乳腺癌中上调的白细胞介素-19 促进肿瘤进展并影响临床结局。
Clin Cancer Res. 2012 Feb 1;18(3):713-25. doi: 10.1158/1078-0432.CCR-11-1532. Epub 2011 Dec 20.
9
Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.磷酸化 Akt 表达是早期非小细胞肺癌的预后标志物。
J Clin Pathol. 2014 Apr;67(4):333-40. doi: 10.1136/jclinpath-2013-201870. Epub 2013 Nov 21.
10
Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.CD10表达对浸润性乳腺癌临床结局的预后影响
Breast Cancer. 2015 Mar;22(2):117-28. doi: 10.1007/s12282-013-0459-1. Epub 2013 Apr 11.

引用本文的文献

1
Cytokine Networks in Triple-Negative Breast Cancer: Mechanisms, Therapeutic Targets, and Emerging Strategies.三阴性乳腺癌中的细胞因子网络:机制、治疗靶点及新兴策略
Biomedicines. 2025 Aug 8;13(8):1945. doi: 10.3390/biomedicines13081945.
2
Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology.从药物基因组学和表观基因组学角度解析肿瘤学中 IL-10 阻断的谜团。
Expert Rev Mol Med. 2024 Jan 8;26:e1. doi: 10.1017/erm.2023.26.
3
Association of Interleukin-10 Polymorphism (rs1800896, rs1800871, and rs1800872) With Breast Cancer Risk: An Updated Meta-Analysis Based on Different Ethnic Groups.
白细胞介素-10基因多态性(rs1800896、rs1800871和rs1800872)与乳腺癌风险的关联:基于不同种族群体的最新荟萃分析
Front Genet. 2022 Feb 4;13:829283. doi: 10.3389/fgene.2022.829283. eCollection 2022.
4
Interleukin-10: A double-edged sword in breast cancer.白细胞介素-10:乳腺癌中的一把双刃剑。
Tzu Chi Med J. 2021 Feb 24;33(3):203-211. doi: 10.4103/tcmj.tcmj_162_20. eCollection 2021 Jul-Sep.
5
Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: a meta-analysis.白细胞介素 10 rs1800896 多态性与乳腺癌易感性的关联:一项荟萃分析。
J Int Med Res. 2020 Apr;48(4):300060520904863. doi: 10.1177/0300060520904863.
6
High-intensity interval training can modulate the systemic inflammation and HSP70 in the breast cancer: a randomized control trial.高强度间歇训练可以调节乳腺癌的全身炎症和 HSP70:一项随机对照试验。
J Cancer Res Clin Oncol. 2019 Oct;145(10):2583-2593. doi: 10.1007/s00432-019-02996-y. Epub 2019 Aug 10.
7
A Survey on the Role of Interleukin-10 in Breast Cancer: A Narrative.白细胞介素-10在乳腺癌中作用的综述:一篇述评
Rep Biochem Mol Biol. 2018 Oct;7(1):30-37.
8
Characterization of Apoptosis in a Breast Cancer Cell Line after IL-10 Silencing.白细胞介素-10沉默后乳腺癌细胞系中细胞凋亡的特征分析
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):777-783. doi: 10.22034/APJCP.2018.19.3.777.
9
Breast Cancer Survivors, Common Markers of Inflammation, and Exercise: A Narrative Review.乳腺癌幸存者、炎症常见标志物与运动:一项叙述性综述
Breast Cancer (Auckl). 2017 Nov 24;11:1178223417743976. doi: 10.1177/1178223417743976. eCollection 2017.
10
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients.IL-6 和 IL-10 与早期浸润性乳腺癌患者的良好预后相关。
Cancer Immunol Immunother. 2018 Apr;67(4):537-549. doi: 10.1007/s00262-017-2106-8. Epub 2017 Dec 18.